Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Veronika Fedirko Image

      Veronika Fedirko, PhD, MPH

      Department of Epidemiology, Division of Cancer Prevention and Population Sciences

      About Dr. Veronika Fedirko


      Read More

      Present Title & Affiliation

      Primary Appointment

      Professor, Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Member, Quantitative Sciences Program, UTHealth Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Adjunct Associate Professor, Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA

      Dual/Joint/Adjunct Appointment

      Professor, Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Research Interests


      I am a molecular cancer epidemiologist with primary research interest in the etiology and prevention (primary and tertiary) of gastrointestinal cancers.  I am particularly interested in investigating how dietary, lifestyle, environmental, metabolomic and microbiome factors combine and interact in producing cancer in humans, and how cancer and its progression can be prevented by lifestyle modifications and/or chemopreventive agents

      Education & Training

      Degree-Granting Education

      2009Emory University, Atlanta, Georgia, US, Cancer and Molecular Epidemiology, PhD
      2005Rollins School of Public Health, Emory University, Atlanta, Georgia, US, Epidemiology, MPH
      2003National University of Kyiv-Mohyla Academy (NaUKMA), Kyiv, UA, Environmental Studies, MS(c)
      2002National University of Kyiv-Mohyla Academy (NaUKMA), Kyiv, UA, Natural Sciences, BS

      Postgraduate Training

      2009-2011Postdoctoral Fellow, International Agency for Research on Cancer, Lyon

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2020 - 2025

      Associate Professor, Department of Epidemiology, Rollins School of Public Health, Winship Cancer Institute, Emory University, Atlanta, Georgia, 2019 - 2020

      Visiting Assistant Professor, Department of Clinical Epidemiology, Aarhus University, Aarhus, 2017 - 2022

      Member, Nutrition and Health Sciences (NHS) Program, Rollins School of Public Health, Emory University, Atlanta, Georgia, 2015 - 2021

      Member, Cancer Prevention and Control Research Program, Winship Cancer Institute (WCI), Emory University, Atlanta, Georgia, 2012 - 2021

      Assistant Professor, Department of Epidemiology, Rollins School of Public Health, Winship Cancer Institute, Emory University, Atlanta, Georgia, 2012 - 2019

      Scientist, Section of Nutrition and Metabolism, Nutritional Epidemiology Group, International Agency for Research on Cancer, Lyon, 2011 - 2012

      Intramural Institutional Committee Activities

      Reviewer, Faculty Achievement Awards, The University of Texas MD Anderson Cancer Center, 2026 - Present

      Chair, Faculty Mid-Term Tenure Track Review Committee, The University of Texas MD Anderson Cancer Center, 2026 - Present

      Reviewer, CPRIT High Impact High Risk (HIHR), The University of Texas MD Anderson Cancer Center, 2025 - Present

      Reviewer, OncoPitch Review Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Reviewer, MAC Cohort, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Associate Program Leader, Cancer Risks & Outcomes (CRO) Program, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Member, Workforce Communities and Connections Council (WCCC), The University of Texas MD Anderson Cancer Center, 2025 - Present

      Member, Multidivisional Shark Tank, The University of Texas MD Anderson Cancer Center, 2024 - Present

      Member, Institutional Alcohol Advisory Taskforce, The University of Texas MD Anderson Cancer Center, 2024 - Present

      Member, Med Tech Innovation Council, The University of Texas MD Anderson Cancer Center, 2024 - Present

      Liaison, Cancer Research Training and Education Coordination (CRTEC), The University of Texas MD Anderson Cancer Center, 2024 - Present

      Chair, Epidemiology Faculty Search Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present

      Member, ORIEN@Winship Molecular Data Task Force, Winship Cancer Institute, Emory University, 2018 - 2020

      Member, Infectious Diseases Epidemiology Faculty Search Committee, Rollins School of Public Health, Emory University, 2018 - 2020

      Member, Women in Winship Committee, Winship Cancer Institute, Emory University, 2018 - 2020

      Member, F99/K00 Review Committee, Winship Cancer Institute, Emory University, 2018 - 2020

      Member, Genetic Epidemiology Faculty Search Committee, Rollins School of Public Health, Emory University, 2014

      Member, PhD in Epidemiology Qualifying Examination Committee, Rollins School of Public Health, Emory University, 2012 - 2020

      Member, PhD in Epidemiology Admissions Committee, Rollins School of Public Health, Emory University, 2012 - 2020

      Editorial Activities

      Associate Editor, Annals of Epidemiology, 2017 - 2022

      Honors & Awards

      2024Faculty Scholar Award, The University of Texas MD Anderson Cancer Center
      2022Andrew Sabin Family Foundation Fellowship Award, The University of Texas MD Anderson Cancer Center
      2020Rising Stars Award, Cancer Prevention & Research Institute of Texas (CPRIT)
      2018Award for the highest AltMetric publication in 2018, Winship Cancer Institute
      2016Best Scientific Poster, NIH Cohort Consortium Meeting
      2016Teaching Award, Department of Epidemiology, Rollins School of Public Health, Emory University
      2009Award for Best Scientific Poster, Winship Cancer Institute
      2009Aflac Scholar-in-Training Award, American Association for Cancer Research (AACR)
      2008Scholar-in-Training Award, American Association for Cancer Research (AACR)
      2008Emory Graduate School Research Grant (RSPH), Emory University
      2005Delta Omega Society, Honorary Society in Public Health (RSPH)
      2003Edmund S. Muskie Fellowship, U.S. Department of State
      2002BS with Highest Honors, National University of Kyiv-Mohyla Academy
      2002Government Scholarship for Excellence in Studies, National University of Kyiv-Mohyla Academy
      2001International Summer School Scholarship, University of Oslo
      2000Dr. Myroslawa Iwanciw Scholarship for Excellence in Studies, National University of Kyiv-Mohyla Academy

      Professional Memberships

      Society for Immunotherapy of Cancer

      2024 - Present

      American Society of Microbiology

      2023 - Present

      American Society of Clinical Oncology

      2022 - Present

      International Society for Pharmacoepidemiology

      2018 - Present

      American Society for Nutrition

      2015 - Present

      American Society of Preventive Oncology

      2015 - Present

      American Association for Cancer Research

      2006 - Present

      Selected Presentations & Talks

      Local Presentations

      1. 2023. Everything Everywhere All at Once in Colorectal Cancer Prevention & Outcomes. Cancer Prevention & Control Grand Rounds. Invited. Houston, Texas, US.
      2. 2019. Vitamin D and Colorectal Carcinogenesis. Invited. Houston, Texas, US.
      3. 2019. Metabolomics in DLBCL. Invited. Lymphoma Research Collaborative Conference. Atlanta, GA, US.
      4. 2017. Microbiome and MCL. Invited. Lymphoma Research Conference: A Focus on Mantle Cell Lymphoma. Atlanta, GA, US.

      Regional Presentations

      1. 2019. Gut Microbiome Modulating Agents & Colon Cancer Recurrence: a Danish Nationwide Registry-Based Cohort Study. Invited. Innovating with Existing Drugs and Nutraceuticals Conference. Atlanta, GA, US.
      2. 2019. Vitamin D, Gut Barrier Function, and Colorectal Carcinogenesis. Invited. Department of Epidemiology’s Seminar Series. Birmingham, AL, US.

      National Presentations

      1. 2016. Vitamin D in Colorectal Cancer Chemoprevention. Invited. Epidemiology Grand Rounds. Lebanon, NH, US.
      2. 2015. Vitamin D and Colorectal Neoplasms. Invited. Vanderbilt‐Queen’s University Belfast Joint Cancer Epidemiology and Prevention Symposium. Nashville, TN, US.
      3. 2015. Circulating biomarkers of gut barrier function: Correlates and responses to calcium supplementation among sporadic colorectal adenoma patients in a dose-response randomized controlled trial. Invited. 106th Annual Meeting of the American Association for Cancer Research. Philadelphia, PA, US.
      4. 2014. Systemic & Tissue-Specific Effects of Vitamin D in Colorectal Cancer Chemoprevention. Invited. Nutrition seminar. Boston, MN, US.
      5. 2013. Prediagnostic anthropometric measures and survival after diagnosis with colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Invited. 104th Annual Meeting of the American Association for Cancer Research. Washington, DC, US.
      6. 2013. 11.A Pilot Metabolomic Study of the Effects of Vitamin D and Calcium Supplementation. Invited. San Juan, PR.

      International Presentations

      1. 2019. Antibiotic Use And Colorectal Cancer Recurrence And Mortality: A Danish Nationwide Prospective Cohort. Invited. ISPE’s 35th International Conference on Pharmacoepidemiology and Therapeutic Risk Management. Philadelphia, US.
      2. 2019. Vitamin D in Colorectal Cancer Chemoprevention: Colon Tissue-Specific & Systemic Effects. Lyon, FR.
      3. 2019. Advanced Glycation End Products and Survival Among Colorectal Cancer Patients. Invited. Lyon, FR.
      4. 2012. Serum 25-hydroxyvitamin D and risk of breast cancer: Results of a large population-based case-control study in Mexican women. Invited. Rio de Janeiro, BR.
      5. 2012. Dietary carbohydrates, dietary fiber, glycemic index, glycemic load and risk of primary liver cancers within the European Prospective Investigation into Cancer and Nutrition (EPIC). Invited. Rio de Janeiro, BR.
      Read More
      Less

      Selected Publications

      Peer-Reviewed Articles

      1. Chelette, B, Bashaw, A, Bryant, JD, Scott, K, Chidomere, CL, Fedirko, V, West, AP, Dantzer, R. Activation of the cGAS-STING pathway contributes to cancer-related fatigue in a murine model of head and neck cancer. Brain, behavior, and immunity 138, 2026. e-Pub 2026. PMID: 42365905.
      2. Daniel, N, Papadimitriou, N, Chatziioannou, AC, Jenab, M, Mayén, AL, Keski-Rahkonen, P, Fedirko, V, Hassan, MM, Hughes, DJ. Genetically predicted gut bacteria, circulating bacteria-associated metabolites and liver cancer. Digestive and Liver Disease 58(8):1081-1089, 2026. e-Pub 2026. PMID: 42218054.
      3. Xiao C, Miller AH, Paul S, Fedirko V, Peng G, Conneely KN, Felger JC, Shin DM, Saba NF, Bruner DW. Neighborhood Deprivation and Biological and Psychosocial Outcomes for Head and Neck Cancer. JAMA Netw Open 8(10):e2538569, 2025. e-Pub 2025. PMID: 41118167.
      4. Pham TT, Nimptsch K, Aleksandrova K, Jenab M, Fedirko V, Olsen A, Tjonneland A, Cadeau C, Severi G, Schulze MB, Fortner RT, Katzke V, Agnoli C, Sacerdote C, Tumino R, Signoriello S, Trobajo-Sanmartin C, Gomez JH, Chirlaque MD, Sanchez MJ, Crous-Bou M, May A, Heath A, Aune D, Weiderpass E, Pischon T. Circulating fatty acid binding protein 4 (FABP-4) concentrations and mortality in individuals with colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study. Int J Cancer, 2025. e-Pub 2025. PMID: 40857027.
      5. Aglago, E, Ramos, I, Keski-Rahkonen, P, Chatziioannou, C, Freisling, H, Fedirko, V, Gunter, MJ, Dahm, CC, Langmann, F, Bondonno, N, Tjønneland, A, Severi, G, Truong, T, Katzke, VA, Kaaks, R, Bergmann, MM, Schulze, MB, Masala, G, Pala, V, Santucci De Magistris, M, Di Girolamo, C, Lukic, M, Gram, IT, Bonet, C, Sánchez, MJ, Chirlaque, MD, Amiano, P, Guevara, M, Vermeulen, R, Manjer, J, Eriksson, L, Key, T, Mayén, AL, Dossus, L, Weiderpass, EV, Heath, AK, Ferrari, P, Jenab, M. Alcohol and smoking habits in association with hepatocellular carcinoma risk. International journal of cancer 157(4):644-657, 2025. e-Pub 2025. PMID: 40098437.
      6. Yue Y, Mao Y, Read TD, Fedirko V, Satten GA, Chen X, Zhan X, Hu YJ. Integrative analysis of microbial 16S gene and shotgun metagenomic sequencing data improves statistical efficiency in testing differential abundance. J Am Stat Assoc, 2025. e-Pub 2025. PMID: 40857503.
      7. Mandle HB, Fedirko V. Inflammation and Gut Barrier Function-Related Genes and Colorectal Cancer Risk in Western European Populations. Mutagenesis 40(1):48-60, 2025. e-Pub 2025. PMID: 38441165.
      8. Li J, Roshelli Baker J, Aglago EK, Zhao Z, Jiao L, Freisling H, Hughes DJ, Eriksen AK, Tjonneland A, Severi G, Katzke V, Kaaks R, Schulze MB, Masala G, Pala V, Pasanisi F, Tumino R, Padroni L, Vermeulen RCH, Gram IT, Braaten T, Jakszyn PG, Sanchez MJ, Gomez-Gomez JH, Moreno-Iribas C, Amiano P, Papier K, Weiderpass E, Huybrechts I, Heath AK, Schalkwijk C, Jenab M, Fedirko V. Pre-diagnostic plasma advanced glycation end-products and soluble receptor for advanced glycation end-products and mortality in colorectal cancer patients. Int J Cancer 155(11):1982-1995, 2024. e-Pub 2024. PMID: 39057841.
      9. Huang Y-H, Fedirko V. Association of tea and coffee consumption and biliary tract cancer risk: The Biliary Tract Cancers Pooling Project. Hepatology 79(6):1324-1336, 2024. e-Pub 2024. PMID: 38758104.
      10. Pham TT, Nimptsch K, Aleksandrova K, Jenab M, Fedirko V, Wu K, Eriksen AK, Tjønneland A, Severi G, Rothwell J, Kaaks R, Katzke V, Catalano A, Agnoli C, Masala G, De Magistris MS, Tumino R, Vermeulen R, Aizpurua A, Trobajo-Sanmartín C, Chirlaque MD, Sánchez MJ, Lu SSM, Cross AJ, Christakoudi S, Weiderpass E, Pischon T. Pre-diagnostic circulating resistin concentrations and mortality among individuals with colorectal cancer: Results from the European Prospective Investigation into Cancer and Nutrition study. Int J Cancer 154(9):1596-1606, 2024. e-Pub 2024. PMID: 38200695.
      11. Hughes DJ, Schomburg L, Jenab M, Biessy C, Méplan C, Moskal A, Sun Q, Demircan K, Fedirko V, Weiderpass E, Mukhtar M, Olsen A, Tjønneland A, Overvad K, Schulze M, Nøst TH, Skeie G, Olsen KS, Ricceri F, Grioni S, Palli D, Masala G, Tumino R, Pasanisi F, Amiano P, Colorado Yohar SM, Agudo A, Sánchez MJ, Ardanaz E, Sund M, Andersson A, Perez-Cornago A, Travis R, Heath AK, Dossus L. Prediagnostic selenium status, selenoprotein gene variants and association with breast cancer risk in a European cohort study. Free Radic Biol Med 209(Pt 2):381-393, 2023. e-Pub 2023. PMID: 37923090.
      12. Yue Y, Read TD, Fedirko V, Satten GA, Hu YJ. Integrative analysis of microbial 16S gene and shotgun metagenomic sequencing data improves statistical efficiency. Res Sq, 2023. e-Pub 2023. PMID: 37886529.
      13. Xiao C, Fedirko V, Claussen H, Richard Johnston H, Peng G, Paul S, Maner-Smith KM, Higgins KA, Shin DM, Saba NF, Wommack EC, Bruner DW, Miller AH. Circulating short chain fatty acids and fatigue in patients with head and neck cancer: A longitudinal prospective study. Brain Behav Immun 113:432-443, 2023. e-Pub 2023. PMID: 37543249.
      14. Mao Z, Baker JR, Takeuchi M, Hyogo H, Tjønneland A, Eriksen AK, Severi G, Rothwell J, Laouali N, Katzke V, Kaaks R, Schulze MB, Palli D, Sieri S, de Magistris MS, Tumino R, Sacerdote C, Derksen JWG, Gram IT, Skeie G, Sandanger TM, Quirós JR, Crous-Bou M, Sánchez MJ, Amiano P, Colorado-Yohar SM, Guevara M, Harlid S, Johansson I, Perez-Cornago A, Freisling H, Gunter M, Weiderpass E, Heath AK, Aglago E, Jenab M, Fedirko V. Prediagnostic serum glyceraldehyde-derived advanced glycation end products and mortality among colorectal cancer patients. Int J Cancer 152(11):2257-2268, 2023. e-Pub 2023. PMID: 36715363.
      15. Yue Y, Read TD, Fedirko V, Satten GA, Hu YJ. Integrative analysis of microbial 16S gene and shotgun metagenomic sequencing data improves statistical efficiency. bioRxiv, 2023. e-Pub 2023. PMID: 37425938.
      16. Aglago EK, Cross AJ, Riboli E, Fedirko V, Hughes DJ, Fournier A, Jakszyn P, Freisling H, Gunter MJ, Dahm CC, Overvad K, Tjønneland A, Kyrø C, Boutron-Ruault MC, Rothwell JA, Severi G, Katzke V, Srour B, Schulze MB, Wittenbecher C, Palli D, Sieri S, Pasanisi F, Tumino R, Ricceri F, Bueno-de-Mesquita B, Derksen JWG, Skeie G, Jensen TE, Lukic M, Sánchez MJ, Amiano P, Colorado-Yohar S, Barricarte A, Ericson U, van Guelpen B, Papier K, Knuppel A, Casagrande C, Huybrechts I, Heath AK, Tsilidis KK, Jenab M. Dietary intake of total, heme and non-heme iron and the risk of colorectal cancer in a European prospective cohort study. Br J Cancer 128(8):1529-1540, 2023. e-Pub 2023. PMID: 36759722.
      17. Gibbs DC, Barry EL, Fedirko V, Baron JA, Bostick RM. Impact of Common Vitamin D-Binding Protein Isoforms on Supplemental Vitamin D3 and/or Calcium Effects on Colorectal Adenoma Recurrence Risk: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol 9(4):546-551, 2023. e-Pub 2023. PMID: 36701139.
      18. Fedirko V, Kopetz S, Daniel CR. Diverticular disease and cancer risk: More than a gut feeling. J Natl Cancer Inst 115(1):12-13, 2023. e-Pub 2022. PMID: 36200895.
      19. Visvanathan K, Mondul AM, Zeleniuch-Jacquotte A, Wang M, Gail MH, Yaun SS, Weinstein SJ, McCullough ML, Eliassen AH, Cook NR, Agnoli C, Almquist M, Black A, Buring JE, Chen C, Chen Y, Clendenen T, Dossus L, Fedirko V, Gierach GL, Giovannucci EL, Goodman GE, Goodman MT, Guénel P, Hallmans G, Hankinson SE, Horst RL, Hou T, Huang WY, Jones ME, Joshu CE, Kaaks R, Krogh V, Kühn T, Kvaskoff M, Lee IM, Mahamat-Saleh Y, Malm J, Manjer J, Maskarinec G, Millen AE, Mukhtar TK, Neuhouser ML, Robsahm TE, Schoemaker MJ, Sieri S, Sund M, Swerdlow AJ, Thomson CA, Ursin G, Wactawski-Wende J, Wang Y, Wilkens LR, Wu Y, Zoltick E, Willett WC, Smith-Warner SA, Ziegler RG. Circulating vitamin D and breast cancer risk: an international pooling project of 17 cohorts. Eur J Epidemiol 38(1):11-29, 2023. e-Pub 2023. PMID: 36593337.
      20. Barry EL, Fedirko V, Jin Y, Liu K, Mott LA, Peacock JL, Passarelli MN, Baron JA, Jones DP. Plasma Metabolomics Analysis of Aspirin Treatment and Risk of Colorectal Adenomas. Cancer Prev Res (Phila) 15(8):521-532, 2022. e-Pub 2022. PMID: 35653338.
      21. Nimptsch K, Aleksandrova K, Fedirko V, Jenab M, Gunter MJ, Siersema PD, Wu K, Katzke V, Kaaks R, Panico S, Palli D, May AM, Sieri S, Bueno-de-Mesquita B, Standahl K, Sánchez MJ, Perez-Cornago A, Olsen A, Tjønneland A, Bonet CB, Dahm CC, Chirlaque MD, Fiano V, Tumino R, Gurrea AB, Boutron-Ruault MC, Menegaux F, Severi G, van Guelpen B, Lee YA, Pischon T. Pre-diagnostic C-reactive protein concentrations, CRP genetic variation and mortality among individuals with colorectal cancer in Western European populations. BMC Cancer 22(1):695, 2022. e-Pub 2022. PMID: 35739525.
      22. Maltsev D, Fedirko V. Refractory atypical trigeminal neuralgia associated with reactivated herpesvirus infection: pathogenetic link and efficacy of combination antiviral therapy. Virusdisease 33(2):155-165, 2022. e-Pub 2022. PMID: 35991701.
      23. Tan Y, Barr DB, Ryan PB, Fedirko V, Sarnat JA, Gaskins AJ, Chang CJ, Tang Z, Marsit CJ, Corwin EJ, Jones DP, Dunlop AL, Liang D. High-resolution metabolomics of exposure to tobacco smoke during pregnancy and adverse birth outcomes in the Atlanta African American maternal-child cohort. Environ Pollut 292(Pt A):118361, 2022. e-Pub 2022. PMID: 34655695.
      24. Gibbs DC, Barry EL, Fedirko V, Baron JA, Bostick RM. Common vitamin D-binding protein isoform modifies supplemental vitamin D3 and calcium effects on colorectal adenoma risk. JAMA Onc, 2022. e-Pub 2022. PMID: 36701139.
      25. Mao Z, Aglago EK, Zhao Z, Schalkwijk C, Jiao L, Freisling H, Weiderpass E, Hughes DJ, Eriksen AK, Tjønneland A, Severi G, Rothwell J, Boutron-Ruault MC, Katzke V, Kaaks R, Schulze MB, Birukov A, Krogh V, Panico S, Tumino R, Ricceri F, Bueno-de-Mesquita HB, Vermeulen RCH, Gram IT, Skeie G, Sandanger TM, Quirós JR, Crous-Bou M, Sánchez MJ, Amiano P, Chirlaque MD, Barricarte Gurrea A, Manjer J, Johansson I, Perez-Cornago A, Jenab M, Fedirko V. Dietary Intake of Advanced Glycation End Products (AGEs) and Mortality among Individuals with Colorectal Cancer. Nutrients 13(12), 2021. e-Pub 2021. PMID: 34959986.
      26. Kelley CF, Pollack I, Yacoub R, Zhu Z, Van Doren VE, Gumber S, Amara RR, Fedirko V, Kraft CS, de Man TJB, Hu YJ, Grimsley Ackerley C, Sullivan PS, Bostick RM. Condomless receptive anal intercourse is associated with markers of mucosal inflammation in a cohort of men who have sex with men in Atlanta, Georgia. J Int AIDS Soc 24(12):e25859, 2021. e-Pub 2021. PMID: 34911162.
      27. Baker JR, Umesh S, Jenab M, Schomburg L, Tjønneland A, Olsen A, Boutron-Ruault MC, Rothwell JA, Severi G, Katzke V, Johnson T, Schulze MB, Masala G, Agnoli C, Simeon V, Tumino R, Bueno-de-Mesquita HB, Gram IT, Skeie G, Bonet C, Rodriguez-Barranco M, Houerta JM, Gylling B, Van Guelpen B, Perez-Cornago A, Aglago E, Freisling H, Weiderpass E, Cross AJ, Heath AK, Hughes DJ, Fedirko V. Prediagnostic Blood Selenium Status and Mortality among Patients with Colorectal Cancer in Western European Populations. Biomedicines 9(11), 2021. e-Pub 2021. PMID: 34829750.
      28. Aglago EK, Mayén AL, Knaze V, Freisling H, Fedirko V, Hughes DJ, Jiao L, Eriksen AK, Tjønneland A, Boutron-Ruault MC, Rothwell JA, Severi G, Kaaks R, Katzke V, Schulze MB, Birukov A, Palli D, Sieri S, Santucci de Magistris M, Tumino R, Ricceri F, Bueno-de-Mesquita B, Derksen JWG, Skeie G, Gram IT, Sandanger T, Quirós JR, Luján-Barroso L, Sánchez MJ, Amiano P, Chirlaque MD, Gurrea AB, Johansson I, Manjer J, Perez-Cornago A, Weiderpass E, Gunter MJ, Heath AK, Schalkwijk CG, Jenab M. Dietary Advanced Glycation End-Products and Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. Nutrients 13(9), 2021. e-Pub 2021. PMID: 34579010.
      29. Mayén AL, Aglago EK, Knaze V, Cordova R, Schalkwijk CG, Wagner KH, Aleksandrova K, Fedirko V, Keski-Rahkonen P, Leitzmann MF, Katzke V, Srour B, Schulze MB, Masala G, Krogh V, Panico S, Tumino R, Bueno-de-Mesquita B, Brustad M, Agudo A, Chirlaque López MD, Amiano P, Ohlsson B, Ramne S, Aune D, Weiderpass E, Jenab M, Freisling H. Dietary intake of advanced glycation endproducts and risk of hepatobiliary cancers: A multinational cohort study. Int J Cancer 149(4):854-864, 2021. e-Pub 2021. PMID: 33899229.
      30. Aglago EK, Murphy N, Huybrechts I, Nicolas G, Casagrande C, Fedirko V, Weiderpass E, Rothwell JA, Dahm CC, Olsen A, Tjønneland A, Kaaks R, Katzke V, Schulze MB, Masala G, Agnoli C, Panico S, Tumino R, Sacerdote C, Bueno-de-Mesquita BH, Derksen JWG, Skeie G, Gram IT, Brustad M, Jakszyn P, Sánchez MJ, Amiano P, Huerta JM, Ericson U, Wennberg M, Perez-Cornago A, Heath AK, Jenab M, Chajes V, Gunter MJ. Dietary intake and plasma phospholipid concentrations of saturated, monounsaturated and trans fatty acids and colorectal cancer risk in the EPIC cohort. Int J Cancer 149(4):865-882, 2021. e-Pub 2021. PMID: 33913149.
      31. Xiao C, Fedirko V, Beitler J, Bai J, Peng G, Zhou C, Gu J, Zhao H, Lin IH, Chico CE, Jeon S, Knobf TM, Conneely KN, Higgins K, Shin DM, Saba N, Miller A, Bruner D. The role of the gut microbiome in cancer-related fatigue: pilot study on epigenetic mechanisms. Support Care Cancer 29(6):3173-3182, 2021. e-Pub 2021. PMID: 33078326.
      32. Aglago EK, Schalkwijk CG, Freisling H, Fedirko V, Hughes DJ, Jiao L, Dahm CC, Olsen A, Tjønneland A, Katzke V, Johnson T, Schulze MB, Aleksandrova K, Masala G, Sieri S, Simeon V, Tumino R, Macciotta A, Bueno-de-Mesquita B, Skeie G, Gram IT, Sandanger T, Jakszyn P, Sánchez MJ, Amiano P, Colorado-Yohar SM, Gurrea AB, Perez-Cornago A, Mayén AL, Weiderpass E, Gunter MJ, Heath AK, Jenab M. Plasma concentrations of advanced glycation end-products and colorectal cancer risk in the EPIC study. Carcinogenesis 42(5):705-713, 2021. e-Pub 2021. PMID: 33780524.
      33. Linseisen J, Grundmann N, Zoller D, Kühn T, EHJM J, Chajès V, Fedirko V, Weiderpass E, Dahm CC, Overvad K, Tjønneland A, Boutron-Ruault MC, Rothwell JA, Severi G, Kaaks R, Schulze MB, Aleksandrova K, Sieri S, Panico S, Tumino R, Masala G, De Marco L, Bueno-de-Mesquita B, Vermeulen R, Gram IT, Skeie G, Chirlaque MD, Ardanaz E, Agudo A, Sánchez MJ, Amiano P, Wennberg M, Bodén S, Perez-Cornago A, Aglago EK, Gunter MJ, Jenab M, Heath AK, Nieters A. Red Blood Cell Fatty Acids and Risk of Colorectal Cancer in The European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomarkers Prev 30(5):874-885, 2021. e-Pub 2021. PMID: 33619024.
      34. Vermandere K, Bostick RM, Tran HQ, Gewirtz AT, Barry EL, Rutherford RE, Seabrook ME, Fedirko V. Effects of Supplemental Calcium and Vitamin D on Circulating Biomarkers of Gut Barrier Function in Colon Adenoma Patients: a Randomized Clinical Trial. Cancer Prev Res (Phila) 14(3):393-402, 2021. e-Pub 2021. PMID: 33229339.
      35. Gibbs DC, Fedirko V, Baron JA, Barry EL, Flanders WD, McCullough ML, Yacoub R, Raavi T, Rutherford RE, Seabrook ME, Bostick RM. Inflammation Modulation by Vitamin D and Calcium in the Morphologically Normal Colorectal Mucosa of Patients with Colorectal Adenoma in a Clinical Trial. Cancer Prev Res (Phila) 14(1):65-76, 2021. e-Pub 2021. PMID: 32917645.
      36. Aglago EK, Rinaldi S, Freisling H, Jiao L, Hughes DJ, Fedirko V, Schalkwijk CG, Weiderpass E, Dahm CC, Overvad K, Eriksen AK, Kyrø C, Boutron-Ruault MC, Rothwell JA, Severi G, Katzke V, Kühn T, Schulze MB, Aleksandrova K, Masala G, Krogh V, Panico S, Tumino R, Naccarati A, Bueno-de-Mesquita B, van Gils CH, Sandanger TM, Gram IT, Skeie G, Quirós JR, Jakszyn P, Sánchez MJ, Amiano P, Huerta JM, Ardanaz E, Johansson I, Harlid S, Perez-Cornago A, Mayén AL, Cordova R, Gunter MJ, Vineis P, Cross AJ, Riboli E, Jenab M. Soluble Receptor for Advanced Glycation End-products (sRAGE) and Colorectal Cancer Risk: A Case-Control Study Nested within a European Prospective Cohort. Cancer Epidemiol Biomarkers Prev 30(1):182-192, 2021. e-Pub 2021. PMID: 33082206.
      37. Butt J, Jenab M, Werner J, Fedirko V, Weiderpass E, Dahm CC, Tjønneland A, Olsen A, Boutron-Ruault MC, Rothwell JA, Severi G, Kaaks R, Turzanski-Fortner R, Aleksandrova K, Schulze M, Palli D, Pala V, Panico S, Tumino R, Sacerdote C, Bueno-de-Mesquita B, Van Gils CH, Gram IT, Lukic M, Sala N, Sánchez Pérez MJ, Ardanaz E, Chirlaque MD, Palmquist R, Löwenmark T, Travis RC, Heath A, Cross AJ, Freisling H, Zouiouich S, Aglago E, Waterboer T, Hughes DJ. Association of Pre-diagnostic Antibody Responses to Escherichia coli and Bacteroides fragilis Toxin Proteins with Colorectal Cancer in a European Cohort. Gut Microbes 13(1):1-14, 2021. e-Pub 2021. PMID: 33874856.
      38. Byrd DA, Judd S, Flanders WD, Hartman TJ, Fedirko V, Bostick RM. Associations of Novel Dietary and Lifestyle Inflammation Scores with Incident, Sporadic Colorectal Adenoma. Cancer Epidemiol Biomarkers Prev 29(11):2300-2308, 2020. e-Pub 2020. PMID: 32856603.
      39. Gibbs DC, Bostick RM, McCullough ML, Um CY, Flanders WD, Jenab M, Weiderpass E, Gylling B, Gram IT, Heath AK, Colorado-Yohar S, Dahm CC, Bueno-de-Mesquita B, Perez-Cornago A, Trichopoulou A, Tumino R, Kühn T, Fedirko V. Association of prediagnostic vitamin D status with mortality among colorectal cancer patients differs by common, inherited vitamin D-binding protein isoforms. Int J Cancer 147(10):2725-2734, 2020. e-Pub 2020. PMID: 32391587.
      40. Barry EL, Fedirko V, Uppal K, Ma C, Liu K, Mott LA, Peacock JL, Passarelli MN, Baron JA, Jones DP. Metabolomics Analysis of Aspirin's Effects in Human Colon Tissue and Associations with Adenoma Risk. Cancer Prev Res (Phila) 13(10):863-876, 2020. e-Pub 2020. PMID: 32655007.
      41. Bai J, Bruner DW, Fedirko V, Beitler JJ, Zhou C, Gu J, Zhao H, Lin IH, Chico CE, Higgins KA, Shin DM, Saba NF, Miller AH, Xiao C. Gut Microbiome Associated with the Psychoneurological Symptom Cluster in Patients with Head and Neck Cancers. Cancers (Basel) 12(9), 2020. e-Pub 2020. PMID: 32899975.
      42. Byrd DA, Judd SE, Flanders WD, Hartman TJ, Fedirko V, Agurs-Collins T, Bostick RM. Associations of Novel Dietary and Lifestyle Inflammation Scores With Incident Colorectal Cancer in the NIH-AARP Diet and Health Study. JNCI Cancer Spectr 4(3):pkaa009, 2020. e-Pub 2020. PMID: 32455332.
      43. Kühn T, Stepien M, López-Nogueroles M, Damms-Machado A, Sookthai D, Johnson T, Roca M, Hüsing A, Maldonado SG, Cross AJ, Murphy N, Freisling H, Rinaldi S, Scalbert A, Fedirko V, Severi G, Boutron-Ruault MC, Mancini FR, Sowah SA, Boeing H, Jakszyn P, Sánchez MJ, Merino S, Colorado-Yohar S, Barricarte A, Khaw KT, Schmidt JA, Perez-Cornago A, Trichopoulou A, Karakatsani A, Thriskos P, Palli D, Agnoli C, Tumino R, Sacerdote C, Panico S, Bueno-de-Mesquita B, van Gils CH, Heath AK, Gunter MJ, Riboli E, Lahoz A, Jenab M, Kaaks R. Prediagnostic Plasma Bile Acid Levels and Colon Cancer Risk: A Prospective Study. J Natl Cancer Inst 112(5):516-524, 2020. e-Pub 2020. PMID: 31435679.
      44. Aglago EK, Huybrechts I, Murphy N, Casagrande C, Nicolas G, Pischon T, Fedirko V, Severi G, Boutron-Ruault MC, Fournier A, Katzke V, Kühn T, Olsen A, Tjønneland A, Dahm CC, Overvad K, Lasheras C, Agudo A, Sánchez MJ, Amiano P, Huerta JM, Ardanaz E, Perez-Cornago A, Trichopoulou A, Karakatsani A, Martimianaki G, Palli D, Pala V, Tumino R, Naccarati A, Panico S, Bueno-de-Mesquita B, May A, Derksen JWG, Hellstrand S, Ohlsson B, Wennberg M, Van Guelpen B, Skeie G, Brustad M, Weiderpass E, Cross AJ, Ward H, Riboli E, Norat T, Chajes V, Gunter MJ. Consumption of Fish and Long-chain n-3 Polyunsaturated Fatty Acids Is Associated With Reduced Risk of Colorectal Cancer in a Large European Cohort. Clin Gastroenterol Hepatol 18(3):654-666.e6, 2020. e-Pub 2020. PMID: 31252190.
      45. Gibbs DC, Song M, McCullough ML, Um CY, Bostick RM, Wu K, Flanders WD, Giovannucci E, Jenab M, Brustad M, Tjønneland A, Perez-Cornago A, Trichopoulou A, Tsilidis KK, Hultdin J, Barricarte Gurrea A, Bueno-de-Mesquita B, Mahamat-Saleh Y, Kühn T, Gunter MJ, Weiderpass E, Fedirko V. Association of Circulating Vitamin D With Colorectal Cancer Depends on Vitamin D-Binding Protein Isoforms: A Pooled, Nested, Case-Control Study. JNCI Cancer Spectr 4(1):pkz083, 2020. e-Pub 2020. PMID: 32337495.

      Abstracts

      1. Li J, Fedirko V. Effects of Long-Term Aspirin Treatment on the Rectal Mucosa-Associated Microbiome and Adenoma Recurrence. CPRIT Innovations VII: The Cancer Prevention and Research Conference.
      2. Lee S, Bostick RM, Pearce B, Barry EL, Rutherford RE, Seabrook ME, Fedirko V. Effects of supplemental calcium and vitamin D on circulating biomarkers of gut barrier function in colorectal adenoma patients: A randomized controlled trial. American Association for Cancer Research Annual Meeting 2024.
      3. Graciela Bado V, Fedirko V. Baseline Short-Chain Fatty Acids and Neuropsychological Symptom Burden in Patients with Head and Neck Cancer. CPRIT Innovations VII: The Cancer Prevention and Research Conference.

      Book Chapters

      1. Fedirko V, Nead KT, Daniel C, Scheet P. Cancer Epidemiology. In: Holland–Frei Cancer Medicine. Wiley Blackwell, 2022.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 08, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top